Show simple item record

dc.contributor.authorMontilla, Marcela
dc.contributor.authorAtienza Navarro, Isabel 
dc.contributor.authorGarcía Cózar, Francisco José 
dc.contributor.authorCastro González, Carmen 
dc.contributor.authorRodríguez-Martorell, Francisco Javier
dc.contributor.authorRuiz Rodríguez, Félix Alejandro 
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2023-06-14T12:46:09Z
dc.date.available2023-06-14T12:46:09Z
dc.date.issued2022-11
dc.identifier.issn1422-0067
dc.identifier.urihttp://hdl.handle.net/10498/28822
dc.description.abstractPolyphosphate (polyP), a phosphate polymer released by activated platelets, may modulate various stages of hemostasis by binding to blood proteins. In this context, we previously reported that polyP binds to the von Willebrand factor (VWF). One of the most significant functions of VWF is to bind to and protect the blood circulating Factor VIII (FVIII). Therefore, here, we study the role of polyP in the VWF-FVIII complex in vitro and suggest its biological significance. Surface plasmon resonance and electrophoretic mobility assays indicated that polyP binds dynamically to VWF only in the absence of FVIII. Using the VWF Ristocetin Cofactor assay, the most accepted method for studying VWF in platelet adhesion, we found that polyP activates this role of VWF only at low levels of FVIII, such as in plasmas with chemically depleted FVIII and plasmas from severe hemophilia A patients. Moreover, we demonstrated that FVIII competes with polyP in the activation of VWF. Finally, polyP also increases the binding of VWF to platelets in samples from patients with type 2 and type 3 von Willebrand disease. We propose that polyP may be used in designing new therapies to activate VWF when FVIII cannot be used.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceInternational Journal of Molecular Sciences, Vol. 23, Núm. 22, 2022es_ES
dc.subjectfactor VIIIes_ES
dc.subjecthemophilia Aes_ES
dc.subjectpolyphosphateses_ES
dc.subjectvon Willebrand diseaseses_ES
dc.subjectvon Willebrand factores_ES
dc.titlePolyphosphate Activates von Willebrand Factor Interaction with Glycoprotein Ib in the Absence of Factor VIII In Vitroes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/ijms232214118
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//PI10%2F01222/es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/Junta de Andalucía//CTS-554/ES/Metabolismo Del Fosfato En Tejidos Humanos/ es_ES
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional